BioSpace News Archive

Biotech Bay

Full-Body MRI Conditional Labeling Now Available in United States for Nevro Senza® Spinal Cord Stimulation System

Expanding Patient Access to Nevro’s HF10® Therapy Through Broader Imaging Compatibility

March 22, 2018
·
4 min read
Drug Development

vTv Therapeutics Announces Completion of Phase 1b Study Evaluating TTP399 for the Treatment of Type 1 Diabetes

Simplici-T1 is an adaptive Phase 1b/2 study being conducted with support from JDRF.

March 22, 2018
·
5 min read
Drug Development

Phase III data in The Lancet show Novartis siponimod significantly improved outcomes in patients with secondary progressive MS

EXPAND shows oral siponimod is the first investigational disease-modifying therapy in a large trial that meaningfully delayed disability progression in typical secondary progressive MS patients.

March 22, 2018
·
10 min read
Business

Regeneron and Alnylam Team up to Tackle NASH Liver Disease

Regeneron Pharmaceuticals and Alnylam Pharmaceuticals signed a collaboration deal to identify RNAi therapies for nonalcoholic steatohepatitis (NASH) and other possibly related liver diseases.

March 22, 2018
·
2 min read
·
Mark Terry
U.S. House Passes Right-to-Try Legislation on Second Attempt

The second time proved to be the charm for the U.S. House of Representatives to pass right-to-try legislation that would provide terminally ill patients access to experimental drugs without the approval of the U.S. FDA.

March 22, 2018
·
2 min read
·
Alex Keown
Deals

GSK Is Now Favorite to Acquire Pfizer’s Consumer Health Business

Now that Reckitt Benckiser has walked away from a deal, GlaxoSmithKline is now the favorite to acquire Pfizer’s consumer health business.

March 22, 2018
·
2 min read
·
Alex Keown
Drug Development

Poor Mid-Stage Results Sink AbbVie’s Plans for Cancer Drug

After disappointing mid-stage results and discussions with the FDA, AbbVie will not ask for accelerated approval for its lung cancer drug.

March 22, 2018
·
2 min read
·
Mark Terry
Drug Development

Array BioPharma Touts Phase III Results for Melanoma Therapy

Array BioPharma Inc. released detailed results for its late-stage combination treatment for metastatic melanoma.

March 22, 2018
·
2 min read
·
Alex Keown
Biotech Beach

Arena Pharma Raising $352 Million Following Positive Phase II Data

Arena Pharmaceuticals is hoping to raise $352 million from a stock offering just days after releasing positive top-line results from its Phase II trial of etrasimod in ulcerative colitis.

March 22, 2018
·
2 min read
·
Mark Terry
Genetown

Rheos Medicines Launches with $60 Million

Rheos Medicines, backed by Third Rock Ventures, launched with a $60 million Series A financing. The company will focus on immunometabolism to treat disease.

March 22, 2018
·
3 min read
·
Mark Terry